MorphoSys To Release Myelofibrosis Trial Data This Year : vi

Shares of MorphoSys AG (MOR), which have been experiencing strong momentum this year, touched a new 52-week high of $6.85 during intraday trading yesterday..

Related Keywords

China , Spain , Japan , Germany , Italy , France , United Kingdom , Lenalidomide Revlimid , Incyte Jakafi , Incyte Corp , Nasdaq Global Market , Fda , Myelofibrosis , Revlimid , Blood Cancer , Bone Marrow , Morphosys , Monjuvi ,